Intrust Bank’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,679
| Closed | -$289K | – | 366 |
|
|
2019
Q1 | $289K | Sell |
3,679
-343
| -9% | -$26.9K | 0.07% | 300 |
|
|
2018
Q4 | $340K | Sell |
4,022
-1,665
| -29% | -$141K | 0.1% | 238 |
|
|
2018
Q3 | $974K | Buy |
5,687
+30
| +0.5% | +$5.14K | 0.25% | 97 |
|
|
2018
Q2 | $731K | Buy |
5,657
+263
| +5% | +$34K | 0.2% | 130 |
|
|
2018
Q1 | $556K | Buy |
5,394
+649
| +14% | +$66.9K | 0.16% | 169 |
|
|
2017
Q4 | $406K | Buy |
4,745
+648
| +16% | +$55.4K | 0.12% | 238 |
|
|
2017
Q3 | $348K | Buy |
4,097
+639
| +18% | +$54.3K | 0.11% | 253 |
|
|
2017
Q2 | $262K | Sell |
3,458
-304
| -8% | -$23K | 0.09% | 312 |
|
|
2017
Q1 | $248K | Sell |
3,762
-40
| -1% | -$2.64K | 0.09% | 324 |
|
|
2016
Q4 | $241K | Sell |
3,802
-138
| -4% | -$8.75K | 0.09% | 316 |
|
|
2016
Q3 | $251K | Buy |
3,940
+210
| +6% | +$13.4K | 0.1% | 296 |
|
|
2016
Q2 | $278K | Buy |
+3,730
| New | +$278K | 0.11% | 269 |
|